🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this study is to refine and pilot the Relaxation Response Resil...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2017-11-27
Trial ID
NCT03071887
Treatments Being Tested
Based on findings from our prior trials with parents of children with learn...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2022-05-06
Trial ID
NCT05535348
Treatments Being Tested
This is a randomized open pilot trial enrolling up to 40 co-primary caregiv...
Status
Completed
Location
MGH
Start Date
2024-11-01
Trial ID
NCT06492278
Treatments Being Tested
This study has three aims: Phase I: Through focus group interviews with ex...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2016-12
Trial ID
NCT02995408
Treatments Being Tested
The Relaxation Response Resiliency Program (3RP) has shown efficacy in impr...
Status
Active Not Recruiting
Location
Massachusetts General Hospital Cancer Center
Start Date
2024-07-30
Trial ID
NCT05737602
Treatments Being Tested
This study has three aims: Phase I: Through focus group interviews with ex...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2016-09-01
Trial ID
NCT02772432
Treatments Being Tested
The purpose of this study is to pilot an adapted resiliency-based mind-body...
Status
Completed
Location
MatCh Research nit (MRU), a Division of Wits Health Consort
Start Date
2024-10-01
Trial ID
NCT06548035
Treatments Being Tested
The proposed research has the following objectives: Based off findings fro...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2020-01-28
Trial ID
NCT04369417
Treatments Being Tested
The Relaxation Response Resiliency Program (3RP) was developed by researche...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2017-08-03
Trial ID
NCT03212261
Treatments Being Tested